Dietary Nitrate and Muscle Power with Aging

Dietary Nitrate and Muscle Power with Aging
Recruiting
65 years - 79 years
All
Phase N/A
1 Location

Brief description of study

The purpose of this study is to see if drinking beetroot juice (BRJ) is beneficial for aging subjects.

Detailed description of study

After you complete a screening visit, if you are determined to be eligible, your participation in the study would involve 6 separate outpatient visits at the Indiana Clinical Research Center at IU-Health University Hospital at 550 University Boulevard in Indianapolis, each 1 week apart.  For each visit you will fast for 12 hours.  On the first day you will drink beet juice and have your muscle function tested. Samples of your blood and muscle will also be obtained during this visit. Your muscle sample will be obtained by numbing the thigh muscle and making a small incision, and then inserting a needle into the muscle to obtain a small piece of muscle tissue.  This procedure is typically painless with only a small amount of pressure being felt.  This visit will take approximately 5 hours.  After this experiment is over, you would be given a 1 week supply of the beet juice to take with you and drink daily, and you will return 1 week later to provide a blood sample (12 hour fast required) .  This visit will take approximately 1 hour.  At this point, you will be given another 1 week supply of beet juice, then return to repeat the same experiment as before where you perform the exercise test and provide blood (12 hour fast required) and muscle samples (about 5 hours). After a 2 week “washout” period without drinking beet juice, the above described sequence of tests will then be repeated. During the study you will also wear an activity monitor which tracks how much physical activity you are doing.  In total, your participation in the study will last about 2 months.
Participants will be compensated up to $1000 for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy
  • Age: 65 years - 79 years
  • Gender: All

Inclusion:
  • Men and women age 65-79
  • In good health, as determined by a review of your medical history, physical examination, EKG, and routine blood and urine tests 
Exclusion:
  • Men and women <65 or >79 years of age
  • Unable to provide informed consent
  • Currently pregnant or lactating
  • Current smokers
  • Significant orthopedic limitations or other contraindications to strenuous exercise
  • Those taking phosphodiesterase inhibitors (e.g., Viagra, Levitra, or Cialis)
  • Those taking proton pump inhibitors, antacids, xanthine oxidase inhibitors, or on hormone replacement therapy
  • Those taking anti-coagulants (e.g., Coumadin) or on anti-platelet therapy
  • History of major metabolic disease (e.g., type I and type II diabetes, thyroid disorders), neuromuscular disease (e.g., cervical spondylotic radiculomyelopathy, lumbar spondylosis, amyotrophic lateral sclerosis, Guillain-Barré syndrome, and acquired demyelinating polyneuropathies), cardiovascular disease (e.g., > stage II hypertension, heart failure, myocardial infarction/ischemia, significant myocardial or pericardial diseases (e.g. amyloidosis, constriction), moderate or severe valvular disease, renal disease, liver disease, or anemia

Updated on 04 Aug 2024. Study ID: 1712579448

Pre-Screener

Check your eligibility-Test
Take up this questionnaire to help us determine if you have symptoms that are common to this clinical study. If you have the common symptoms, you may be eligible to take part in the study.

Preview complete

The prescreener preview is complete. You may now close the preview.

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team